XOMA
XOMA RoyaltyBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
XOMA vs peer average
61/100
XOMA vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · C 3 · D 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
LGND is the first available peer comparator.
Ligand is the most relevant strategic reference because it is the announced acquirer and another royalty aggregator, though it is a larger buyer rather than a clean trading peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
XOMA
XOMA Royalty
LGND
Ligand
Grade
B
B
Momentum
82
86
Value
49
58
Sentiment
42
31
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs LGND
XOMA / LGND
Grade Position
In line
XOMA vs. peer average (B vs. C)
61/100
Momentum
82
LGNDValue
49
LGNDSentiment
42
XOMARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs XOMA
LGND is the first peer returned for this comparison set.